305 related articles for article (PubMed ID: 33140318)
1. Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy.
Lowe SC; Sauk JS; Limketkai BN; Kwaan MR
J Gastrointest Surg; 2021 Jan; 25(1):211-219. PubMed ID: 33140318
[TBL] [Abstract][Full Text] [Related]
2. Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: A nationwide administrative database analysis.
Yoshida S; Imai S; Fushimi K
J Gastroenterol Hepatol; 2024 Feb; 39(2):272-279. PubMed ID: 37961024
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Mortality After Nonelective Surgery for Inflammatory Bowel Disease Patients in the Era of Biologics.
Justiniano CF; Aquina CT; Becerra AZ; Xu Z; Boodry CI; Swanger AA; Monson JRT; Fleming FJ
Ann Surg; 2019 Apr; 269(4):686-691. PubMed ID: 29232213
[TBL] [Abstract][Full Text] [Related]
5. Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016.
Qvist N; Vadstrup K; Alulis S; Borsi A; Munkholm P; Olsen J
Scand J Gastroenterol; 2021 May; 56(5):537-544. PubMed ID: 33736551
[TBL] [Abstract][Full Text] [Related]
6. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
7. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study.
Khoudari G; Mansoor E; Click B; Alkhayyat M; Saleh MA; Sinh P; Katz J; Cooper GS; Regueiro M
Clin Gastroenterol Hepatol; 2022 May; 20(5):e974-e983. PubMed ID: 33065311
[TBL] [Abstract][Full Text] [Related]
8. A nationwide study of patients hospitalized with indeterminate colitis: a comparison with Crohn's disease and ulcerative colitis.
Prakash S; Tanaka T; Ashat D
Int J Colorectal Dis; 2023 Aug; 38(1):223. PubMed ID: 37650980
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis.
Mabeza RM; Vadlakonda A; Chervu N; Ebrahimian S; Sakowitz S; Yetasook A; Benharash P
Surg Obes Relat Dis; 2024 Feb; 20(2):146-152. PubMed ID: 38030456
[TBL] [Abstract][Full Text] [Related]
10. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease.
Bressler B; Jones J; In TSH; Lan T; Iconaru C; Marshall JK
Adv Ther; 2023 Oct; 40(10):4421-4439. PubMed ID: 37507652
[TBL] [Abstract][Full Text] [Related]
11. Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease.
Ananthakrishnan AN; McGinley EL
Aliment Pharmacol Ther; 2013 May; 37(9):895-904. PubMed ID: 23451882
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
13. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
[TBL] [Abstract][Full Text] [Related]
14. Trends in hospitalization rates for inflammatory bowel disease in the United States.
Bewtra M; Su C; Lewis JD
Clin Gastroenterol Hepatol; 2007 May; 5(5):597-601. PubMed ID: 17382602
[TBL] [Abstract][Full Text] [Related]
15. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
Szántó K; Nyári T; Bálint A; Bor R; Milassin Á; Rutka M; Fábián A; Szepes Z; Nagy F; Molnár T; Farkas K
PLoS One; 2018; 13(7):e0200824. PubMed ID: 30059523
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway.
Zhao M; Lirhus S; Lördal M; Langholz E; Knudsen T; Voutilainen M; Høivik ML; Moum B; Anisdahl K; Saebø B; Haiko P; Malmgren C; Coskun M; Melberg HO; Burisch J
Aliment Pharmacol Ther; 2022 Sep; 56(6):989-1006. PubMed ID: 35902223
[TBL] [Abstract][Full Text] [Related]
17. Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?
Hatch QM; Ratnaparkhi R; Althans A; Keating M; Neupane R; Nishtala M; Johnson EK; Steele SR
J Gastrointest Surg; 2016 Nov; 20(11):1867-1873. PubMed ID: 27634305
[TBL] [Abstract][Full Text] [Related]
18. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
Jung YS; Han M; Kim WH; Park S; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
[TBL] [Abstract][Full Text] [Related]
20. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
Cai Q; Ding Z; Fu AZ; Patel AA
BMC Gastroenterol; 2022 Dec; 22(1):545. PubMed ID: 36581802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]